PNPLA2 and metabolic syndrome: Additionally, our analysis showed that three of the examined factors, i.e., metabolic syndrome, obesity, and AS160 silencing, affected the expression of the ATGL protein in subADMSCs-derived adipocytes (39%, 37%, and 18% of data variability, respectively).